Skip to main content
An official website of the United States government
Email

NCI Funding Helps Bring New AI-Aided Device for Glioblastoma to Market

If you’re using imaging to manage glioblastoma (GBM) and looking for an artificial intelligence (AI) solution, you’ll be interested in this latest success story from NCI’s Small Business Innovation Research program. It could help make your AI-guided GBM segmentation easier.

With support from NCI’s SBIR program, which helps small businesses with research and development, a new cyber device (called “i2Contour”) recently received clearance from the U.S. Food and Drug Administration. The tool, developed by MRIMath, LLC, of Birmingham, AL, gives you an interpretable, physician-in-the-loop, AI-aided approach for measuring and labeling GBM.

According to company co-founder, Dr. Hassan Fathallah-Shaykh, i2Contour’s interactive user interface can help you accurately outline tumors, visualize AI's explanations and volumetric measurements, and review analysis results.

He added, “Using this approach allows you not only to comply with federal standards for managing medical data but is easily incorporated into clinical workflows so you can collaborate, plan, and monitor treatment tailored to each patient.”

Said Dr. Fathallah-Shaykh, “Our goal with this tool is to assist physicians in producing accurate tumor segmentation and volumetric analysis within minutes. It’s the first in what we hope will be a full suite of AI models to support research and care in the cancer and neuroscience fields.”

< Older Post

NCI-Funded Researchers Develop Tool for Deciphering Telomeres

Newer Post >

ARPA-H Biomedical Data Fabric (BDF) Toolbox Program Announces Awardees

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “NCI Funding Helps Bring New AI-Aided Device for Glioblastoma to Market was originally published by the National Cancer Institute.”

Archive

Email